Clarifying my letter

A Abbass - CMAJ, 2003 - Can Med Assoc
During the editing process, a shift occurred in content of my letter to the editor 1 that I wish to
correct. The statement that we need to stop “pharmaceutical companies from controlling …

The heart of the matter

JP Veinot - CMAJ, 2003 - Can Med Assoc
During the editing process, a shift occurred in content of my letter to the editor1 that I wish to
correct. The statement that we need to stop “pharmaceutical companies from controlling …

[PDF][PDF] Comments on “Presidential Address: Advocacy as Leadership”

S Replies - academia.edu
TO THE EDITOR: As psychiatrists and APA members, who also work in the pharmaceutical
industry, we are writing to address what we feel are incorrect statements made by Steven S …

[PDF][PDF] Standards for Psychotherapy: Some Regulatory Aspects

M Paré, B Walsh, LA Dawson - From the Editor (cont'd), 2015 - mdpac.ca
The purpose of this ongoing column is to help ensure that Primary Care Physicians, General
Practitioners (GPs) and Family Physicians (FPs) in Ontario are acquainted with the …

Treating the mentally ill

R Peele, L Kline, B Herman - Health Affairs, 2001 - healthaffairs.org
To the Editor: Over the past twenty years the pharmaceutical industry has brought us some
terrific new drugs that ease pain and suffering and make our lives better and more …

" One size fits all" doesn't work with medicines

KK Shearin - Journal of the National Medical Association, 2003 - search.proquest.com
" The dumbing down of medicine will disproportionately affect us," Rahn Kennedy Bailey,
MD, said during" The Impact of Restricting Physicians' Therapeutic Choice". Patrice Harris …

How we are progressing towards the goals of the manifesto

J Caballero - Mental Health Clinician, 2011 - meridian.allenpress.com
With the establishment of the College of Psychiatric and Neurologic Pharmacists (CPNP)
manifesto and Dr. Stimmel's vision, our members need to evaluate how we as a profession …

Letter of Response to Letters by Drs Kline and Maurer

SA Rappaport - Journal of the American Medical Directors Association, 2009 - jamda.com
There is valid and essential pharmaceutical research, but we write the prescriptions. We
don't do the research. We cannot protect our patients by spending an hour analyzing papers …

[CITATION][C] Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial

C Chaloner - Mental Health Practice, 2012 - go.gale.com
THIS IS a true story about the influence that drug companies exert on clinical practice and
the impact this has on clinicians, researchers and patients. At the heart of what is a well-told …

Protection after medical error

RN Merchant - CMAJ, 2003 - Can Med Assoc
Iappreciated CMAJ's recent editorial on drug marketing, 1 but I wish to highlight here a major
medical education issue that is usually overlooked, in part because of the influence wielded …